SIRT5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.213500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.617600E-01
Normal-vs-Stage2
1.089230E-01
Normal-vs-Stage3
3.595900E-02
Normal-vs-Stage4
4.760400E-01
Stage1-vs-Stage2
9.614200E-01
Stage1-vs-Stage3
4.795600E-02
Stage1-vs-Stage4
4.706200E-01
Stage2-vs-Stage3
3.031500E-02
Stage2-vs-Stage4
4.419000E-01
Stage3-vs-Stage4
1.479450E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.634400E-02
Normal-vs-AfricanAmerican
2.554800E-01
Normal-vs-Asian
6.904000E-01
Caucasian-vs-AfricanAmerican
3.887400E-01
Caucasian-vs-Asian
3.558200E-01
AfricanAmerican-vs-Asian
1.687220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.781600E-02
Normal-vs-Female
1.332830E-01
Male-vs-Female
5.299600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.330800E-01
Normal-vs-Age(41-60Yrs)
5.429900E-02
Normal-vs-Age(61-80Yrs)
9.326200E-02
Normal-vs-Age(81-100Yrs)
3.326600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.846600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.424800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.337600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.928010E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.657800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.611210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.397800E-01
Normal-vs-Daily Drinker
4.933600E-02
Normal-vs-Weekly Drinker
6.605800E-02
Normal-vs-Occasional Drinker
9.272300E-02
Normal-vs-Social Drinker
2.202800E-01
Non Drinker-vs-Daily Drinker
3.671200E-01
Non Drinker-vs-Weekly Drinker
5.471800E-01
Non Drinker-vs-Occasional Drinker
8.528200E-01
Non Drinker-vs-Social Drinker
6.347000E-01
Daily Drinker-vs-Weekly Drinker
8.291800E-01
Daily Drinker-vs-Occasional Drinker
4.095200E-01
Daily Drinker-vs-Social Drinker
1.207210E-01
Weekly Drinker-vs-Occasional Drinker
5.733000E-01
Weekly Drinker-vs-Social Drinker
1.995210E-01
Occasional Drinker-vs-Social Drinker
4.155600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.004190E-02
Normal-vs-Grade 2
1.148390E-02
Normal-vs-Grade 3
3.521700E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.139000E-01
Grade 1-vs-Grade 3
5.337500E-02
Grade 1-vs-Grade 4
1.004190E-02
Grade 2-vs-Grade 3
4.143600E-01
Grade 2-vs-Grade 4
1.148390E-02
Grade 3-vs-Grade 4
3.521700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.938000E-02
Normal-vs-NonDiabetic
1.112430E-01
Diabetic-vs-NonDiabetic
1.255180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.677600E-01
Normal-vs-NoPancreatitis
1.078650E-01
Pancreatitis-vs-NoPancreatitis
9.210600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.935500E-02
Normal-vs-N1
9.576400E-02
N0-vs-N1
8.631200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.001800E-01
Normal-vs-TP53-NonMutant
3.288800E-01
TP53-Mutant-vs-TP53-NonMutant
2.794400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
